|

Chronic
stress negatively impacts many of the body's functions,
but Flavay Plus™ can help.
Research
shows that Flavay Plus™ can lower stress-induced
hormone (cortisol) production by 30 percent.
|
Experts now believe that chronic
stress can be a factor in any disease.
Chronic
Stress Alters
Immune Function
Stress is interpreted by the body
as a danger signal and results in the "fight or flight"
response which affects both the brain and immune system.Your
adrenal glands release cortisol which allows your body to defend
itself through heightened awareness, increased heart rate, and
increased blood flow to muscles. Cortisol also has the ability to
alter the immune system's production of white blood cells, and to
cause them to migrate to particular areas of the body during times
of injury, infection, and stress.
However, during periods of
chronic stress, continued activation of the immune system persists
like the "boy who cried wolf," in that the danger
signals are ignored because of their persistence.
Mobilization
of Immune Cells Produces Free Radicals
Flavay™
can restore cytokine imbalances and thereby normalize
white blood cell activity—normalizing immune function.
|
Chemical messengers called
"cytokines" go to work, sending messages to the brain
that cause more white blood cells to mobilize. The more white
blood cells your body activates, the more free radicals they
produce. These free radicals are among your immune system's most
powerful weapons, during periods of emotional stress and disease,
in response to injury, and even in the aging process itself.
Research demonstrates that Flavay™ may restore cytokine
imbalances and normalize white blood cell activity, thereby
normalizing immune function.
Flavay™
Scavenges the Body's Terrorists:
Rampaging Free Radicals
Free radicals are like pellets of
poison that destroy invaders by interfering with their cellular
machinery, literally dissolving or breaking down the genetic
material of bacteria, toxins and viruses.
When all is going well, the
immune system is capable of identifying foreign invaders such as
viruses and bacteria by accurately "reading" molecular
codes found on cell surfaces. These molecular codes are like flags
of different armies, and the immune system will not attack a cells
if it "reads" a flag belonging to the body's own host
army. Unfortunately, however, free radicals can interfere with the
biological components of our healthy cells, just as they destroy
invaders. This leads to many diseases.
Flavay™
can help regulate a healthy balance of nitric oxide
in the body.
|
When the immune system's
cytokines activate macrophages (the white blood cells capable of
gobbling up invading viruses and bacteria), the macrophages
produce large amounts of nitric oxide in the course of battle.
Nitric oxide is a colorless gas produced by different cells in the
body that, depending on the situation, can be very good
or very bad. Research has shown that Flavay™ works to
keep nitric oxide within normal limits in the body.
Chronic
Stress Alters Cardiovascular Function
When we are under stress, our
adrenaline flows and causes our blood vessels to constrict,
increasing blood pressure, and blood platelets are
activated—prepared to clump together to form a clot. This
"fight or flight response" is appropriate in short-term
dangerous situations. The blood platelets are prepared for an
injury to more quickly form a blood clot and more efficiently
prevent blood loss.
Chronic stress causes constant
constriction of blood vessels and continuously "sticky"
blood platelets, always prepared to form a clot. These are classic
risk factors for heart disease and stroke. When blood vessels are
constricted there is less area for the blood to flow through and
atherosclerotic plaque may further reduce the space for blood
flow. If some blood platelets stick together and form a clot, the
vessel may be completely clogged and surrounding tissue is
deprived of oxygen and nutrients. This is how a heart attacks and
strokes develop.
Flavay™
improves nitric oxide levels which causes blood
platelets to return to their normal, smooth condition.
|
Research shows that Flavay™
improves nitric oxide levels produced by cells that line the
arteries. Nitric oxide controls the muscles surrounding the blood
vessels and causes them to relax. At the same time, nitric oxide
causes blood platelets to return to their normal, smooth
condition.
Flavay™
and the Nitric Oxide Connection
Nitric oxide is a colorless gas
produced by different cells in the body that, depending on the
situation, can be very good or very bad. Nitric
oxide plays several important roles in the body:
- Nitric oxide is an important
signaling molecule that turns genes on and off.
- By controlling the muscular
tone of blood vessels, nitric oxide regulates the
circulation and normalizes blood flow.
- Nitric oxide modulates
communication between brain cells and is instrumental in
helping us concentrate and learn new information, and also
in maintaining memory.
- When produced by immune
cells, nitric oxide fights infection, kills tumor cells and
promotes wound healing.
- Nitric oxide is essential
for perceiving pleasure and pain, and it helps translate
sexual excitement into penile erections.
- Nitric oxide aids in
digestion of food by helping to control gastric movements.
But nitric oxide can be very
destructive under other circumstances:
- Nitric oxide restricts blood
flow.
- When produced in excess by
immune cells, nitric oxide can trigger chronic inflammation,
which can cause arthritis, colitis, inflammatory bowel
disease and possibly cancer.
- Nitric oxide promotes
production of more free radicals.
- In the brain, nitric oxide
can hamper mental function and cause memory loss and brain
aging.
The real trouble starts when
nitric oxide encounters the superoxide free radical and becomes
peroxynitrate, which destroys antioxidants like glutathione,
vitamin E and common flavonoids, and damages proteins in the body.
The good news is that Flavay™ scavenges peroxynitrate and has a
remarkable modulatory effect on nitric oxide—helping to maintain
optimal levels in the body and neutralizing this free radical
where it does harm.
"Radical
Scavenger Effect" of Flavay™
Protected by U.S. Patent No. 4,698,360
Originally patented and licensed
in France for therapeutic uses, Flavay™ is the very
product—used in the actual experiments—by which Dr. Jack
Masquelier established and patented the "radical scavenger
effect."
|
"[A]
method for preventing and fighting the harmful
biological effects of free radicals in the
organism of warm blooded animals and more especially human
beings, namely cerebral involution, hypoxia following
atherosclerosis, cardiac or cerebral infarction, tumour
promotion, inflammation, ischaemia, alterations of the
synovial liquid, collagen degradation, among others. The
method consists in administering to said animals and
especially to human beings an amount, efficient against
said effects, of a plant extract with a proanthocyanidins
content which has a radical scavenger effect"—Dr.
Jack Masquelier, U.S. Patent No. 4,698,360.
|
Flavay™
is the product—used in the actual experiments—by
which Dr. Jack Masquelier established and patented the "Radical
Scavenger Effect."
|
During any challenge to your
immune system—because of disease, infections, toxic exposure,
stress or aging—you need the extra antioxidant power in Flavay™
to help scavenge the free radicals naturally produced by
the immune system's cells during warfare. When your immune system
works better, your joints hurt less and your blood flows better.
Flavay™
Increases the Activity of Vitamins C and E
Flavay™ recycles and
significantly extends the lifetime of vitamin C and potentiates
vitamin E, and thereby creates a more powerful, synergistic
antioxidant defense in the body. This is important because
vitamins C and E are key players in the body's protective
antioxidant army.
Antioxidants fight corrosive and
destructive forces that constantly work to break down our bodies.
Overwhelming scientific evidence demonstrates that those of us who
eat a diet rich in antioxidants and take antioxidant supplements
will live longer and healthier lives. Working as a defensive army,
antioxidants work together in the body to maintain our health and
vigor by protecting us from damage caused by rampaging free
radicals which, like terrorists, injure healthy cells and tissues.
Don't underestimate the threat
that free radicals pose to our health. Contemporary scientists now
believe that free radicals are causal factors in nearly every
known disease, from heart disease to arthritis to Parkinson's to
Alzheimer's to ALS to multiple sclerosis to cataracts to the aging
process itself.
As a free radical fighter, Flavay™
comes to the aid of the body more quickly than other antioxidants,
reducing the potential for free radical damage and the ravages of
aging. Flavay™ also possesses more reactive sites for
neutralizing free radicals than other known antioxidants.
Furthermore, Flavay™ permits reactivity with both positively and
negatively charged free radical species. What this means is that
Flavay™ can “quench” or “scavenge” (neutralize) a broad
variety of free radicals. Highly reactive as an antioxidant in
both lipid (fat) and aqueous (water) phases, Flavay™ neutralizes
oxygen free radicals and is a valuable protector of healthy cells
in a variety of internal conditions. This is a unique property
among antioxidants, as most work either in lipid or aqueous
phases, but not both. As a free radical scavenger, Flavay™ is
like an antioxidant prize fighter that can successfully take on
all challengers, big or small, in any kind of weather.
Flavay
Plus™ Provides Synergistic Help
for Confronting Stress
|
Flavay
Plus™ boosts the weak stress response in the elderly
person and calms down exaggerated stress in the healthy
young person.
|
Flavay
Plus™ contains a synergistic blend of Flavay™ with
antioxidant vitamins, minerals and other phytonutrients to best
take advantage of the dynamic interplay among the antioxidants and
their co-factor nutrients. Of particular interest is phosphatidyl
serine, as research has shown that it may have the capacity to
normalize the stress-induced activation of the above-described,
"fight or flight response."
Phosphatidyl
serine: Flavay Plus™
is formulated with phosphatidyl serine (Leci-PS™), a complex of
amino and fatty acids extracted from soy lecithin, which has
proven to be a safe, potentially effective therapeutic agent in
treating memory deficit disorders and is an often-used supplement
for attention deficit disorders. Phosphatidyl serine has been the
subject of many human clinical trials regarding memory loss, mood,
cognitive performance, learning ability and stress.
Phosphatidyl serine is a
phospholipid that is vital to brain cell structure and function.
Phospholipids are molecules containing both amino and fatty acid
components, which are found in every cell membrane in our bodies.
Phosphatidyl serine plays an important role in our
neurotransmitter systems, in metabolism levels of the brain, and
in maintaining nerve connections in the brain. It appears to help
reestablish the normal down-regulation of cortisol secretion that
is increased in chronically stressed individuals.
Research has shown that
phosphatidyl serine works to keep the brain’s processes within
normal limits, raising them when they are low and lowering them
when they are high. So phosphatidyl serine boosts the weak stress
response in the elderly person and calms down exaggerated stress
in the healthy young person. Both physical and mental stressful
conditions cause stress hormones to be released into circulation,
even in the young and healthy. Phosphatidyl serine given to
athletes prior to starting exercise produced an impressive degree
of down-regulation of the stress hormones. Phosphatidyl serine may
have the capacity to normalize the stress-induced activation of
the "fight or flight response." In a double-blind,
placebo-controlled study conducted in Italy, phosphatidyl serine
lowered stress hormone (cortisol) production by 30 percent.
|
Flavay
Plus™ blends phosphatidyl serine with Flavay™ and
other antioxidants and
B vitamins because researchers show that phosphatidyl
serine works better with other nutrients such as the B
vitamins and antioxidants.
|
Two more recent placebo
controlled studies confirmed the earlier double-blind trials;
young, university students experienced significantly less stress
from tests when they took phosphatidyl serine (300 mg daily for 30
days), they stayed more clear-headed and composed, and kept a more
stable mood.
Flavay™:
More Than 50 Years of Protection
Now available in the United
States, Flavay™ is
the actual polyphenol that has been licensed and sold in France
for vascular benefits since 1950. And, Flavay
Plus™ includes the highest-quality phosphatidyl serine and
other antioxidant nutrients and their co-factors in order to offer
you and your family with the best help that nutritional science
has to offer for confronting the stressful challenges of living in
today's world.
CLICK HERE TO SEE WHAT
ACTUAL CUSTOMERS ARE SAYING
Statements made herein have not been
evaluated by the Food and Drug Administration. These products are not intended
to diagnose, treat, cure or prevent any disease.
|
REFERENCES:
Top
|
Masquelier, J. Plant extract with
a proanthocyanidins content as a therapeutic agent having radical scavenging
effect and use thereof. U.S. Patent No. 4,698,360, 1987.
Masquelier, J. A lifetime devoted to OPC and Pycnogenols. Alfa Omega Editrice,
Pub., 1996.
Schwitters, B., Masquelier, J. OPC in practice. Alfa Omega Editrice, Publishers,
1995.
Kilham, C., Masquelier, J. OPC: The miracle antioxidant. Keats Publishing,
Inc., 1997.
Mindell, E., et al. Earl Mindells vitamin bible for the 21st century.
Warner Books, Inc., 1999.
Passwater, R.A. The antioxidants: the nutrients that guard your body. Keats
Publishing, Inc., 1985.
Barilla, J. et al. The nutrition superbook: volume 1: the antioxidants.
Keats Publishing, Inc., 1995.
Lieberman, S., et al. The real vitamin & mineral book: going beyond
the RDA. Avery Pub., 1990.
__ , Based on the results of this controlled study of men with heart disease,
the authors conclude that vitamin B-6 deficiency may influence vascular
connective tissue and thrombogensis (clotting). Atherosclerosis 55 (Ju 1985):
357-361.
__ , Experiments giving animals diets deficient in vitamin B-6 have resulted
in an enhanced risk of cardiovascular disease and other experiments suggest
the same may be true in humans. Medical Hypotheses 15 (De 1984):361-367.
__ , Low levels of vitamin B-6 my increase the risk of heart attack. American
Journal of Cardiology 63 (1989): 513-516.
Carper, J., The miracle heart. HarperCollins Publishers, 2000.
Facino RM, et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from Vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Kuttan R, et al. Collagen treated with catechin becomes resistant to the
action of mammalian collagenase. Experientia, 37: 221-223, 1981.
Masquelier, J., et al. Stabilization du collagene par les oligomeres procyanidoliques.
Acta Therapeutica, 7:101-105, 1981.
Masquelier, J. Aspects pharmacologiques nouveaux de certains flavonoides.
A Vie Medical 12:1969.
Laparra, J., et al. Etude pharmaco-cinetique des oligomers procyandoliques
totaux du raisin. Acta Therapeutica, 4, 1978.
Laparra, J., et al. Etude pharmacocinetique des oligomeres flavonoliques.
Plantes med et phyto, Tome XI, pp. 133-142, 1977.
Robert A.M.; Groult, N.; Six, C.; Robert, L. Etude de laction des
oligomeres procyanidoliques sur des cellules mesenchymateuses en culture.
Ii lattachment des fibres elastiques aux cellules. (Study of the effect
of procyanidolic oligomers on mesenchymal cells in culture. Ii attachment
of elastic fibers to the cells.) Pat Biol, (30)6:601-7, 1990.
Porter, Lawrence J., Wong Rosalind Y. Chan, Bock G. The molecular and crystal
structure of (+)-2,3-trans-3,4-trans-leucocyanidin [(2r,3s,+r)-(+)-3,3,
4.4, 5.7-Hexahydroxyflavan] dihydrate, and comparison of its
heterocyclic ring conformation in solution and the solid state. Journal
of the Chemical Society; Perkin Transactions I 1985. pp. 1413-17.
Masquelier, J. Proanthocyanidins et radicaux libres. 1985.
Uchida, S., et al. Condensed tannins scavenge active oxygen free radicals.
Med Sci Res, (15) 1987. pp. 831-832.
Ariga, T. Radical scavenging action and its mode in procyanidins b-1 and
b-3 from azuki beans to peroxyl radicals. Agric Biol Chem, 54(10) 1990.
pp. 2499-2504.
Da Silva, R., et. al. Radical scavenger capacity of different procyanidins
from grape seeds. Presented at a symposium, Free radicals in biotechnology
and medicine. Royal Society Of Chemistry, London January 1990, pp.
79-80.
Bauman, J., Wurm, G., Bruchhausen, F. Hemmung der prostagladinsynthetase
durch flavonoide und phenolderivate im vergleich nit deren 02 radikalfangereigenschaften
Arch Pharm, (Weinheim) 313 (1980) pp. 330-337.
Lombard, J., et al. The brain wellness plan. Kensington Pub. Corp., 1998.
Flesch M., et al., Effects of red and white wine on endothelium-dependent
vasorelaxation of rat aorta and human coronary arteries. Am J Physiol 1998;275:1183-94.
Fitzpatrick, D.F., Fleming R.C., Bing B, Maggi DA, O'Malley RM. Isolation
and characterization of endothelium-dependent vasorelaxing compounds from
grape seeds. J Agr & Food Chem In press.
Fitzpatrick, D.F., Maggi D, Bing B, Coffey RG. Vasorelaxation, endothelium,
and wine. BioFactors 1997;6:455-459.
Fitzpatrick, D.F., Hirschfield SL, Ricci T, Jantzen P, Coffey RG. Endothelium-dependent
vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol
1995;26:90-95.
Fitzpatrick, D.F., Hirschfield SL, Coffey RG. Endothelium-dependent vasorelaxing
activity of wine and other grape products. Amer J Physiol 1993;265:H774-H778.
Lincoln, J., Hoyle, C.H.V., Burnstock, G., Nitric oxide in health and disease.
Cambridge University Press, 1997.
Libby, P., Ridker, P.M., Maseri, A. Inflammation and atherosclerosis. Circulation
2002 Mar 5; 105(9): 1135-43.
Lindahl, B. et al. Markers of myocardial damage and inflammation in relation
to long-term mortality in unstable coronary artery disease. FRISC Study
Group. Fragmin during Instability in Coronary Artery Disease. N. Engl. J.
Med. 2000 Oct 19; 343(16): 1139 47.
Mendall, M.A., et al. In the largest study of its kind published to date,
researchers report that hospitalized heart patients who took antibiotics
had a significantly lower risk of returning to the hospital with severe
chest pain within one year compared with those on a placebo. Circulation:
Journal of the American Heart Association, Aug. 20, 2002.
Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P., Hennekens, C.H.
Inflammation, aspirin, and the risk of cardiovascular disease in apparently
healthy men. N. Engl. J. Med. 1997 Apr 3; 336(14): 973-9.
Facino, R.M., et al. Free radical scavenging action and anti-enzyme activities
of procyanidines from vitis vinifera. A mechanism for their capillary protective
action. Arzneimittelforschung, 44: 592-601, 1994.
Kuttan, R., Donnelly, P.V., Di Ferrante, N. Collagen treated with catechin
becomes resistant to the action of mammalian collagenase. Experientia, 37:
221-223, 1981.
Masquelier, J. Procyanidolic oligomers. J Parums Cosm Arom, 95: 89-97, 1990.
Tixier, J.M., et al. Evidence by in vivo and in vitro studies that binding
of pycnogenols to elastin affects its rate of degradation by elastases.
Biochem Pharmacol, 33: 3933-3939, 1984.
Kakegawa, H., et al. Chem. Pharm. Bull. 33:5079, 1985.
Harmand, M.F., Blanquet, P. The fate of total flavanolic oligomers extracted
from vitus vinifera l. in the rat. European Journal of Drug
Metabolism and Pharmaccokinetics. 1978, No. 1 pp. 15-30.
Delrieu, P., Ding J., Escande, B., Samain, D. Free-radical scavenging activity
of proanthocyanidolic oligomers encapsulated in glycospheres: an in vivo
and in vitro study. Cosmetology Department & S Biovectors, Ramonville
St. Agne France. pp. 1-9.
Meunier, M.T., Villie, F., et al. Inhibition of angiotensin i converting
enzyme by flavanolic compounds: in vitro and in vivo studies. Planta
Medica,
May 26, 1986. pp. 12-15.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez lanimal-oedenme de la patte. Sanofi Res Toul Cedex Fr, pp31-40.
Barbier, A., et al. Activite angioprotectrice des oligomeres procyanidolques
chez lanimal-activite aniagoniste vis-a-vis des mediateurs de linflamation.
Sanofi Res Toul Cedex Fr, pp. 31-40.
Dubos, C., Durst, G., Hugonot, H. Evolution de la resistance
capillaire,
spontanement ou artificiellement diminuee par laction dune substance
capillaro-toxique chez des personnes agees--action benefique dun agnet
actif sur la micro-circulation: lEndotelon. Inform. Therapeut. 1980.
pp. 302-305.
Dartenuc, J.Y., et al. Resistance capillaire en geriatrie etude dun
microangioprotecteur-Endotelon. Bordeaux Med. 13:903-7, 1990.
Lagrue, G., Olivier-Martin, F., Grillot, A. Etude des effets des oligomeres
du procyanidol sur las resistance capillaire dand lhypertension arterielle
et certaines nephropathies. Sen. Hosp. Paris 18-25 Septembre, 1981.
Beylot, C., Bioulac, P. Essai therapeutique dun angioprotecteur
peripherique,
lEndotelon. Actualite Therapeutique Gaz. Med. de France (87)22:2919-24,
1980.
Lesbre, F.X., Tigaud, J.D. Effect de lEndotelon sur lindice
de fragilite capillaire dan une population specifique: les sujets
cirrhotiques. Gaz. Med. de France, (90)24 1983.
Sarrat, L. Abord therapeutique des troubles fonctionnels des membres inferieurs
par un microangioprotecteur lEndotelon. Bordeaux Med, 11:685-8, 1981.
Delacroix, P. Etude en double aveugle de lEndotelon dans linsuffisance
veineuse chronique. Therapeutique, la Revue de Medicine, (27-28) Sept. 1981.
pp. 1793-1802.
Thebaut, J.F, Thebaut, P., Vin, F. Etude de lEndotelon dand les manifestations
fonctionnelles de linsuffisance veineuse peripherique-resultats dune
etude en double aveugle portant sur 92 patients. Gazette Medicale,
(92)1, 1985. pp. 96-100.
Wegrowski, J., Robert, A.M., Maczar, M. The effect of procyanidolic oligomers
on the composition of normal and hypercholesterolemic rabbit aortas.
Biochem. Pharmacol, (33)21. 1984. pp. 3491-3497.
Chang, W.C., Hsu, F.L. Inhibition of platelet aggregation and arachidonate
metabolism in platelets by procyanidins. Prostagland Leukotri Essent Fatty
Acids, 38:181-8, 1989.
Masquelier, J. Pycnogenols: recent advances in the therapeutical activity
of procyanidins. Supplement of Planta Medica, Journal of Medicinal Plant
Research and Journal of Natural Products, July 1980 pp. 243-256.
Henning, B., et al. Lipid peroxidation and endothelial cell injury: implications
in atherosclerosis. Free Rad Path & Med, (4)1988 pp. 99-106.
Masquelier, J. Les procyanidols du vin leur role dans lalcoolisme.
pp. 88-93.
Gazave, J.M. Notions recentes sur les capillaires
unpub. bulletin
from the Laboratoire De Physiologie Patholigie pp. 26-29.
Ruf, J.C. Wine and polyphenols related to platelet aggregation and
atherothrombosis.
Office International Vigne et du Vin, Nutrition and Health Unit, Paris France;
Drugs under Experimental and Clinical Research (Switz.) 25/2-3 (125-131),
1999.
Blaszo, G. Gabor, M. Oedema-inhibiting effect of
procyanidin. Acta Physiologica
Academiae Scientiarum Hungaricae, Tomus 56(2):235-240, 1980.
Tayau, M.F, LeFevre, G. Action du leucocyanidol sur lhyalaluronidase.
Bull Soc Pharm Bordeaux, 95:132-136, 1956.
Lamy, M. Utilization des oligomeres procyanidoliques en
gynecologie. Essai
Therapeutique Tomel (14) Sept. 2, 1981. pp. 1021-22.
Henriet, J.P Une Etude Exemplaire Pour Un
Phlebotrope: letude EIVE. Unpub., pp. 77-83.
Pfister, A., Simon, M.T., Gazave, J.M. Sites de fixation des oligomeres
procyanidoliques dans la paroi des capillaires sanguins du poumon decobaye.
Acta Therapeutica (8) 1982. pp. 223-237.
Kuttan, R., Donnelly, P., Di Ferrante, N. Collagen treated with (+)
-catechin becomes resistant to the action of mammalian
collagenase.
Laboratory of Connective Tissue Research, Dept. of Biochem. Baylor Col.
of Med., Houston TX. 28, May, 1980.
Gendre, P., Laparra, J., Barraud, E. Effect protecteur des oligomeres
procyanidoliques sur le lathyrisme experimental chez le rat. Ann.
Pharm. Francaises, (43)1, 1985 pp. 61-73.
Corbe, C., Boissin, J.P., Siou, A. Light vision and chorioretinal circulation.
Study of the effect of procyanidolic oligomer (Endotelon). Jn. Fr.
Opthalmol,
(11)5:453-460, 1988.
Boissin, J.P., Corbe C., Siou, A. Chorioretinal circulation and dazzling:
use of procyanidol oligomers (Endotelon). Bull Soc Ophtalmol Fr, 88(2):173-4,
177-9, 1988.
Proto, F. et al. Electrophysical study of vitis vinifera procyanoside oligomers
effects on retinal function in myopic subjects. Ann Ott Clin Ocul, 114:85-93,
1988.
Saracco, J.B., Estachy, G.M. Etude d lEndotelon en
opthalmologie.
Gaz Med de France, 88:2035-2038, 1981.
Scharrer, A., Ober, M. Anthocyanosides in the treatment of retinopathies.
Klin Monatsbl Augenheilkd, 178:386-389, 1981.
Corbe, C., et al. Microangiopathy of the retina. J. Fr.
Opthalmol, 11:453,
1988.
Verin, M.M., Vildy, A., Maurin, J.F., Retinopathies et
O.P.C. Bordeaux Medicale,
(16)11. pp. 1467-74, 1978.
Soyeux, A. et al. Endotelon. Diabetic retinopathy and
hemorheology. Bull
Soc Ophtalmol Fr. 87(12):1441-4, 1987.
Fromantin, M. Les oligomeres procyanidoliques dans le traitement de
la fragilite capillaire et de la retinopathie chez les diabetiques. A propos
de 26 cas. Med Int, 16(11):432-434, Nov. 1981.
Arne, J.L. Contribution a letude des oligomeres procyanidoliques:
Endotelon, dans la retinopathie diabetique (a propos de 30 observations).
Gaz. Med. de France, Vol. 89, No. 30, Oct. 8, 1982.
Baruch, J. Effect of Endotelon in postoperative edema. Results of a double-blind
study versus placebo in 32 female patients. Ann Chir Plast Esthet 29(4):393-5,
1984.
Rao, C.N. et al. Influence of bioflavonoids on the collagen metabolism in
rats with adjuvantinduced arthritis. Ital J Biochem. 30:54-62, 1981.
Gabor, M. Pharmacologic effects of flavonoids on blood vessels. Angiologica,
9:355-374, 1972.
Havsteen, B. Flavonoids, a class of natural products of high pharmacological
potency. Biochem Pharmacol, 32:1141-48, 1983.
Reimann, H.J., Lorenz, W., Fischer, M., Frölich, R., Meyer, H.J. Berkhauser
Verlag, Vol. 7/1, Univ. of Marburg/Lahn, Ger., 1977.
Masquelier, J. Action protectrice du vin sur lulcere gastrique. Resultats,
p. 61.
Amella, M., et al. Inhibition of mast cell histamine release by flavonoids
and bioflavonoids. Planta Medica, 5116-20, 1985.
Packer, L., et al. The antioxidant miracle: your complete plan. John Wiley
& Sons, Inc., 1999.
Shaw, R. How [Australian] PycnoGenol [MASQUELIERs®] Helps Sports
People.
Masquelier, J. Procyanidolic oligomers (leucocyanidins). Parfums Cosmet
Arom 95:89-97, 1990.
Pecking, A., Desprez-Curely, J.P., Megret, G. Oligomers procyanidoliques
(Endotelon) dans le traitement des lymphoedemes post-therepeutiques de members
superieurs. Symposium Satellite, Congres International dAngiologie,
Toulouse, France, 4-7 Oct. 1989.
Fahey, T.D., Pearl M. Hormonal effects of phosphatidylserine during 2 weeks
of intense training. Abstract submitted to national meeting of the Amer
College of Sports Medicine, June 1998.
Monteleone, P., Maj, M., Beinat, L., Natale, M., Kemali, D. Blunting by
chronic phosphatidylserine administration of the stress-induced activation
of the hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharm
43: 385388, 1992.
Fahey, T.D., et al. The hormonal and perceptive effects of phosphatidylserine
administration during two weeks of resistive exercise-induced overtraining.
Bio of Sport 15(3):135-44, 1998.
Laparra, J., Michaud, J. Masquelier, J. Action des oligomeres procyanidoliques
sur le cobaye carence en vitamin c. Tavaux Originaux, University of Bordeaux,
1976.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur loxydation
de lacide ascorbique par les ions cuivriques. Bull. de la Societe
de Chimie Biologique XXXIII (3-4) 1951. pp. 302-304.
Masquelier, J. Action comparee de divers facteurs vitaminiques p sur lacide
ascorbique-oxydase. Bull. de la Societe de Chimie Biologique XXXIII (3,4)
1951. pp.304-306
Kakegawa, H., Matsumoto, H., Endo, K., Satoh, T., Nonaka, G., Mishioka,
I. Inhibitory effects of tannins on hyaluronidase activation and on
the degranulation from rat mesentery mast cells. Chem. Pharm. Bull.
33(11)1985. 5079-5082.
Reiman, H.J., Lorenz, M., Fischer, R., Frolich, H., Meyer, J. Histamine
and acute haemorrhagic lesions in rat gastric mucosa: prevention of stress
ulcer formulation by (+)-catechin, an inhibitor of specific histidine decarboxylase
in vitro. Dirkhauser Verlag,Vol. 7/1, 1977.
Pariente, J.J. Parientl-Amsellem, J. Les oedemes post-traumatoqies
chez le sportif: essai controle de lEndothelon. Actualite Therapeutique
90(3) 2/11 1983 pp. 231-235.
Masquelier, J., et al. Flavonoids et Pycnogenols Int J Vit Nut
Res, (49)3:307-311, 1979.
Yu, C. L. et al. Mutagenicity of proanthocyanidins. Food Chem. Toxicol.
25(2):135-9, 1987.
Pantaleoni, G.C., Quaglino, D. Univerisity of Aquila Pharmacol-Toxicologica
Report, 1971.
Laparra, J., et al., Acta Therapeutica, 4:233, 1978.
Volkner, Wolfgang Muller, Ewald, Micronucleus assay in bone marrow cells
of the mouse with Pycnogenol. Cytotest Cell Research GmbH & Co., projects
143010 & 143021; Feb. 1989.
Acute and chronic toxicity tests. International Bio-Research, Inc., Hanover,
Germany, 1967-1971.
Dumon, M., Michaud, J., Masquelier, J. Proanthocyanidin content in vegetable
extracts to be used in the preparation of medicines. Bull. Soc. Pharm. Bordeaux,
129:51-65, 1990.
Cheon, B.S.; Kim, Y.H.; Son, K.S.; Wook Chang, H; Sik Kang, S.; Pyo Kim,
H. Planta. Med., 2000, 66, 596.
Virgili, F.; Kim, D.; Packer, L. FEBS Lett., 1998, 431, 315.
Kim, H.K.; Cheon, B.S.; Kim, Y.H.; Kim, S.Y.; Kim, H.P. Biochem. Pharmacol.,
1999, 58, 759.
Kidd, P.M. Phosphatidylserine: the nutrient that accelerates all brain functions
and counters Alzheimers disease: Keats Pub. 1998.
Cenacchi T, et al. Cognitive decline in the elderly: A double-blind, placebo-controlled
multicenter study on efficacy of phosphatidylserine administration. Aging,
5: 123133, 1993.
Maggioni M, Picotti GB, Bondiolotti GP et al. Effects of phosphatidylserine
therapy in geriatric patients with depressive disorders. Acta Psychiatr
Scand. 81: 265270, 1990.
Brambilla, F., Maggioni, M., Panerai, A.E., et al. Beta-endorphin concentration
in peripheral blood mononuclear cells of elderly depressed patientseffects
of phosphatidylserine therapy. Neuropsychobiology, 34: 1821, 1996.
Monteleone P., Maj M., Beinat L., Natale M., Kemali, D. Blunting by chronic
phosphatidylserine administration of the stress-induced activation of the
hypothalamo-pituitary-adrenal axis in healthy men. Eur J Clin Pharm, 43:
385388, 1992.
Cenacchi T, et al., Cognitive decline in the elderly: A double-blind,
placebo-controlled multicenter study on efficacy of phosphatidylserine administration.
Aging, 5, 123-133, 1993
Funfgeld, E.W., Baggen, M., Nedwidek, P., Richstein, B., Mistlberger, G.
Double-blind study with phosphatidylserine in parkinsonian patients with
senile dementia of Alzheimers type (SDAT). Prog Clin Biol Res, 317:1235-46,
1989. |
|